Apoptosis in Primary Hyperparathyroidism

J Invest Surg. 2018 Aug;31(4):328-332. doi: 10.1080/08941939.2017.1303101. Epub 2017 Mar 31.

Abstract

Primary hyperparathyroidism (PHPT) is defined by inappropriate elevation of parathormone, caused by parathyroid hyperplasia, also known as multi-gland disease (MGD), parathyroid adenoma (PA), or parathyroid carcinoma (PC). Although several studies have already been conducted, there is a lack of a definite diagnostic marker, which could unambiguously distinguish MGD from PA or PC. The accurate and prompt diagnosis has the key meaning for effective treatment and follow-up. This review paper presents the role of apoptosis in PHPT. The comparison of the expression of Fas, TRAIL, BCL-2 family members, p53 in MGD, PA, and PC, among others, was described. The expression of described factors varies among proliferative lesions of parathyroid gland; therefore, these could serve as additional markers to assist in the diagnosis.

Keywords: apoptosis; parathyroid adenoma; parathyroid carcinoma; parathyroid hyperplasia; primary hyperparathyroidism.

MeSH terms

  • Apoptosis Regulatory Proteins / analysis*
  • Apoptosis Regulatory Proteins / metabolism
  • Apoptosis*
  • Biomarkers / analysis
  • Biomarkers / metabolism
  • Humans
  • Hyperparathyroidism, Primary / diagnosis
  • Hyperparathyroidism, Primary / pathology*
  • Hyperplasia / diagnosis
  • Hyperplasia / pathology
  • Parathyroid Glands / cytology
  • Parathyroid Glands / pathology*
  • Parathyroid Neoplasms / diagnosis
  • Parathyroid Neoplasms / pathology*

Substances

  • Apoptosis Regulatory Proteins
  • Biomarkers